Report of the 2019 NIST-FDA workshop on standards for next generation sequencing detection of viral adventitious agents in biologics and biomanufacturing.

Adventitious virus testing assures product safety by demonstrating the absence of viruses that could be unintentionally introduced during the manufacturing process. The capabilities of next-generation sequencing (NGS) for broad virus detection in biologics have been demonstrated by the detection of known and novel viruses that were previously missed using the recommended routine assays for adventitious agent testing. A meeting was co-organized by the National Institute of Standards and Technology and the U.S. Food and Drug Administration on September 18-19, 2019 in Gaithersburg, Maryland, USA, to facilitate standardization of NGS technologies for applications of adventitious virus testing in biologics. The goal was to assess the currently used standards for virus detection by NGS and their public availability, and to identify additional needs for different types of reference materials and standards (natural and synthetic). The meeting focused on the NGS processes from sample preparation through sequencing but did not thoroughly cover bioinformatics, since this was considered to be the topic of a separate meeting.

[1]  R. L. Charlebois,et al.  Cataloguing the Taxonomic Origins of Sequences from a Heterogeneous Sample Using Phylogenomics: Applications in Adventitious Agent Detection , 2014, PDA Journal of Pharmaceutical Science and Technology.

[2]  Crystal Jaing,et al.  Viral Nucleic Acids in Live-Attenuated Vaccines: Detection of Minority Variants and an Adventitious Virus , 2010, Journal of Virology.

[3]  Mojca Milavec,et al.  Inter-laboratory assessment of different digital PCR platforms for quantification of human cytomegalovirus DNA , 2017, Analytical and Bioanalytical Chemistry.

[4]  Arifa S Khan,et al.  Advanced Virus Detection Technologies Interest Group (AVDTIG): Efforts on High Throughput Sequencing (HTS) for Virus Detection , 2016, PDA Journal of Pharmaceutical Science and Technology.

[5]  C. Foy,et al.  Instability of 8E5 calibration standard revealed by digital PCR risks inaccurate quantification of HIV DNA in clinical samples by qPCR , 2017, Scientific Reports.

[6]  E. Uberbacher,et al.  Ebolavirus comparative genomics , 2015, FEMS microbiology reviews.

[7]  Jim F Huggett,et al.  Highly reproducible absolute quantification of Mycobacterium tuberculosis complex by digital PCR. , 2015, Analytical chemistry.

[8]  Maria Paola Sassi,et al.  Assessment of Digital PCR as a Primary Reference Measurement Procedure to Support Advances in Precision Medicine. , 2018, Clinical chemistry.

[9]  Mojca Milavec,et al.  International Comparison of Enumeration-Based Quantification of DNA Copy-Concentration Using Flow Cytometric Counting and Digital Polymerase Chain Reaction. , 2016, Analytical chemistry.

[10]  I. Nookaew,et al.  Rapid Sequencing of Multiple RNA Viruses in Their Native Form , 2018, bioRxiv.

[11]  P. Duncan,et al.  Systematic evaluation of in vitro and in vivo adventitious virus assays for the detection of viral contamination of cell banks and biological products. , 2014, Vaccine.

[12]  R. L. Charlebois,et al.  A Multicenter Study To Evaluate the Performance of High-Throughput Sequencing for Virus Detection , 2017, mSphere.

[13]  Arifa S. Khan,et al.  Identification of a Novel Rhabdovirus in Spodoptera frugiperda Cell Lines , 2014, Journal of Virology.

[14]  Raju V. Misra,et al.  Development of a candidate reference material for adventitious virus detection in vaccine and biologicals manufacturing by deep sequencing , 2015, Vaccine.